What is Mediwound Ltd (MDWD) stock price today?

Mediwound Ltd (MDWD) currently trades at $16.25 per share. The stock has a market capitalization of $208.85M and a P/E ratio of —x.

Is MDWD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Mediwound Ltd has a Smart Value Score of 18/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Mediwound Ltd's revenue and earnings?

Mediwound Ltd has trailing twelve-month (TTM) revenue of $16.96M with profit margins of -140.80%. Earnings per share (EPS) is $-2.10.

Is MDWD stock overvalued or undervalued?

Based on our DCF model, Mediwound Ltd's intrinsic value is $47.66, representing a margin of safety of 63.81%. The stock currently trades at a P/E of —x.

MDWD

Mediwound Ltd

NASDAQ: MDWD · HEALTHCARE · BIOTECHNOLOGY

$16.25

-1.87% today

Updated 2026-04-29

Market cap

$208.85M

P/E ratio

—

P/S ratio

12.31x

EPS (TTM)

$-2.10

Dividend yield

—

52W range

$15 – $23

Volume

0.1M

Market cap

$208.85M

P/E ratio

—

P/S ratio

12.31x

EPS (TTM)

$-2.10

Dividend yield

—

52W range

$15 – $23

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$31.33

+92.80%

12-Month target

—

Intrinsic (DCF)

$47.66

Margin of safety

+63.81%

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 63.81% below intrinsic value

Risks

- Thin margins at -140.80%

- Negative free cash flow $-5.23M

- Revenue declining -68.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$26.50M	$18.69M	$20.22M	$16.96M	$16.96M
Net income	$-19.60M	$-6.72M	$-30.22M	$-23.88M	$-7.18M
EPS	—	—	—	—	$-2.10
Free cash flow	$-12.44M	$-16.93M	$-19.90M	$-20.04M	$-5.23M
Profit margin	-73.97%	-35.94%	-149.46%	-140.80%	-140.80%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MDWD	$208.85M	18	2.7	2.0	6.7	5.0	+63.81%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Mediwound Ltd trades at $16.25. Our Smart Value Score of 18/100 indicates the stock is weak. TTM revenue stands at $16.96M. with profit margins at -140.80%. Our DCF model estimates intrinsic value at $47.66.

Frequently asked questions

What is Mediwound Ltd's stock price?

Mediwound Ltd (MDWD) trades at $16.25.

Is Mediwound Ltd overvalued?

Smart Value Score 18/100 (Grade F, Strong Sell). DCF value $47.66.

What is the price target of Mediwound Ltd (MDWD)?

The analyst target price is $31.33, representing +92.8% upside from the current price of $16.25.

What is the intrinsic value of Mediwound Ltd (MDWD)?

Based on our DCF model, intrinsic value is $47.66, a +63.8% margin of safety versus $16.25.

What is Mediwound Ltd's revenue?

TTM revenue is $16.96M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12.31x

ROE-63.90%

Beta0.15

50D MA$17.02

200D MA$17.87

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MDWD vs LLY →MDWD vs JNJ →MDWD vs ABBV →Stock screener →